Related Party Transactions and Outside Related Director Information

Biogen, Inc. (Retired) (BGEN.X)

In August 2002, we entered into an agreement with Craig Eric Schneier, Executive Vice President Human Resources, in which our existing commitment to provide Dr. Schneier with a $250,000 mortgage loan was cancelled in exchange for our agreement to reimburse Dr. Schneier for the additional interest expense he would incur to his commercial lender resulting from such cancellation. As a result, we will pay Dr. Schneier an additional $1,323 per month beginning on August 15, 2002 and continuing until such time as Dr. Schneier would have been obligated to repay the cancelled mortgage loan in accordance with the terms of the promissory note evidencing the original mortgage commitment, as described in footnote 3 of the preceding table.

In connection with the retirement of James L. Vincent's as Chairman of our Board of Directors, we sold Mr. Vincent certain company assets, the value of which was determined by an independent third party appraiser.

In 2002, Phillip A. Sharp and Kenneth Murray also received payments for their participation on our Scientific Advisory Board ("SAB"). Dr. Sharp, as Chairman of the SAB, received a consulting fee of $75,000 and an option for the purchase of 15,000 shares at an exercise price of $40.13, which fully vested on the grant date. Kenneth Murray received a consulting fee of $20,000 for his service on the SAB. Dr. Sharp and Sir Kenneth Murray each also received $2,000 per day for each SAB meeting attended. The SAB was disbanded in 2002.